Is this you?
Request access for Northwest Houston Heart Center with your @houstonheartcenter.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall69Recruit66Ops71Sponsor68Ther73
Performance (observed)
Historical trials
178
Completed
81
Terminated/Withdrawn
15
Completion rate
84%
Active now
75
Phase 2
21
Phase 3
128
Realized enrollment
1,346,759
First study year
2000
Years active
26
Match confidence
high
Enrollment velocity (inf)
51,798
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
467
States
Texas
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Pfizer; Novartis Pharmaceuticals; Amgen; Alliance for Clinical Trials in Oncology; Eli Lilly and Company
CROs
IQVIA Pvt. Ltd
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
dburns@houstonheartcenter.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall69
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.